Glioblastoma vs Astrocytoma: A Patient Guide

If you or a loved one has been diagnosed with an astrocytoma or glioblastoma (GBM), you likely have many questions and worries. This guide will explain the differences between glioblastoma (Grade IV) and other astrocytoma brain tumor grades (like Grade III anaplastic astrocytoma and lower-grade astrocytomas) in clear, patient-friendly language. We’ll cover what the grades mean, how fast the tumors…

Understanding Brain Tumor Grades (I through IV)

Doctors classify astrocytomas from Grade 1 to 4 based on how the tumor cells look and behave under a microscope, combined with modern molecular testing. The higher the grade, the more aggressive the tumor – meaning it grows faster and invades surrounding brain tissue more readily. Here’s a quick overview of the four grades: Grade I – Pilocytic Astrocytoma: This…

Comparing Grade II vs. Grade III vs. Grade IV Astrocytomas

The table below summarizes key differences between low-grade astrocytoma (Grade II), anaplastic astrocytoma (Grade III), and glioblastoma (Grade IV) – including how fast they grow, what they look like under the microscope, common molecular markers, typical treatments, and prognosis. Feature Grade II Astrocytoma“Low-Grade” (Diffuse Astrocytoma) Grade III Astrocytoma“Anaplastic Astrocytoma” Grade IV Astrocytoma“Glioblastoma” (GBM) WHO Grade II (Low-grade) IV (High-grade, most…

Empowering Patients: Moving Forward After a Diagnosis

Facing an astrocytoma or glioblastoma diagnosis is challenging, but understanding the terminology – Grade II vs. III vs. IV, IDH-mutant vs. IDH-wildtype, etc. – can help you feel more in control. Knowledge equips you to ask the right questions and participate in decisions about your care. Key takeaways and tips: Grade is crucial: It tells you how aggressive the tumor…

Introducing the Mansouri Lab: Advancing Hope Through Brain Tumor Research 

A Message of Hope  At the Glioblastoma Support Network, we know that behind every brain tumor diagnosis is a person searching for answers, options, and hope. That’s why we’re proud to spotlight the launch of the Mansouri Lab website—an initiative led by our board member, neurosurgeon-scientist Dr. Alireza Mansouri.  This lab isn’t just about research—it’s about translating innovation into better…

Brain Tumor Clinical Trials: Why They Matter & How to Find Them

A brain tumor diagnosis can be life-altering, bringing uncertainty for both patients and their loved ones.  While traditional treatments such as surgery, radiation, and chemotherapy remain the standard of care, clinical trials provide an avenue for exploring breakthrough therapies that could improve survival and quality of life. Clinical trials test new drugs, immunotherapies, and targeted treatments that could offer more…

We’re exhibiting at the ABTA 2024 National Conference.

The Glioblastoma Support Network (GSN) is proud to participate in the American Brain Tumor Association’s 2024 National Conference. This event is a crucial gathering for patients, caregivers, and survivors to connect, learn, and gain valuable insights from leading experts in the field of brain tumor research and treatment. About the Conference: The ABTA 2024 National Conference offers a unique opportunity…

What do spouse primary caregivers of patients with glioblastoma want medical providers to know?

Diana L Coman 1, Megan P Chard 1, Lisa Desautels 2, Barbara J Lutz 3, Laurie A Minns 4 Objectives: To analyse the content of letters written by female spouse primary caregivers of patients with glioblastoma multiforme (GBM), a devastating and terminal primary brain cancer, and give voice to their experiences for medical providers of patients with GBM. Design: A qualitative study using reflexive thematic analysis of letters written…

Glioblastoma Support Network Strengthens Commitment to Fighting Brain Cancer with New Board Appointment.

February 22,2024Contact : Lisa A. DeSautelsContact Information: [email protected] FOR IMMEDIATE RELEASEGlioblastoma Support Network Strengthens Commitment to Fighting Brain Cancer with New Board Appointment. Las Vegas, NV February 22, 2024 — The Glioblastoma Support Network (GSN) is proud to announce effective March 15, 2024, the appointment of Cindy Lamb, Lisa Ramey, Dr. Alireza Mansouri, Romeo De Leon, Dr. Scott Glickman and…

Information for Veterans with Glioblastoma Multiforme Brain Cancer

If you or a loved one have been seeking care for glioblastoma multiforme brain cancer at a Veterans Affairs hospital, you aren’t alone. Although few actual brain cancer studies have been done specifically on military personnel and veterans, statistics show that veterans are diagnosed with glioblastoma multiforme more often than members of the general population. Calculations based on data from…

Start typing and press Enter to search

Shopping Cart